GATT Versus Canaloplasty (GVC)
Longterm Comparison of Gonioscopy-assisted Transluminal Trabeculotomy and Canaloplasty in Open-angle Glaucoma Treatment
1 other identifier
interventional
100
1 country
1
Brief Summary
Study aims to compare the effectiveness and safety profile of Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty, in order to find out if one operation is superior to the other. Both procedures are performed in patients with medically uncontrolled open-angle glaucoma. Canaloplasty is a recently newly introduced procedure, which showed encouraging results without antimetabolite usage intra- and postoperatively. Gonioscopy-assisted Transluminal Trabeculotomy is the procedure that aims the same mechanism of aqueous outflow, however is perform with ab interno approach, which comprise it to the minimally invasive glaucoma surgery techniques. Purpose of the study is to compare both surgeries concerning success rate, intraocular pressure, medication burden and complications rate. So far there is no comparison of the Gonioscopy-assisted Transluminal Trabeculotomy and canaloplasty available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMarch 7, 2025
May 1, 2024
3 years
May 4, 2022
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
success rate (complete and qualified success)
Success is defined: 1. IOP \< 21 mmHg and at least 20% IOP change from baseline 2. IOP \< 18 mmHg
12 months
success rate (complete and qualified success)
Success is defined: 1. IOP \< 21 mmHg and at least 20% IOP change from baseline 2. IOP \< 18 mmHg
24 months
Secondary Outcomes (2)
IOP, medication, complications
12 months
IOP, medication, complications
24 months
Study Arms (2)
Canaloplasty
ACTIVE COMPARATORCanaloplasty ab externo
Gonioscopy-assisted Transluminal Trabeculotomy
ACTIVE COMPARATORGonioscopy-assisted Transluminal Trabeculotomy ab interno
Interventions
canaloplasty ab interno with tensioning suture
Gonioscopy-assisted Transluminal Trabeculotomy ab interno
Eligibility Criteria
You may qualify if:
- Years and older (Adult, Older Adult)
- patients with confirmed uncontrolled open angle glaucoma
- no prior glaucoma surgery (once laser trabeculoplasty or cyclophotocoagulation) allowed
You may not qualify if:
- angle closure glaucoma
- congenital glaucoma
- inflammatory glaucoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Bialystoklead
- Medical University of Lublincollaborator
Study Sites (1)
Ophthalmology Clinic Medical University of Bialystok
Bialystok, 15-089, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanna Konopińska
Medical University of Bialystok, Poland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Ophthalomogy, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
May 4, 2022
First Posted
May 9, 2022
Study Start
June 1, 2022
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
March 7, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 5 years
All materials and information are available upon an e-mail request on principal investigator